Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05906134 · ClinicalTrials.gov registry record · Phase 1
Minimally Invasive Esophagectomy Pain Control Trial
A Phase 1 study of Postoperative Complications and Postoperative Pain, Acute, sponsored by Swedish Medical Center.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT05906134: Recruiting Phase 1 study of Postoperative Complications and Postoperative Pain, Acute, sponsored by Swedish Medical Center.
NCT05906134 is a Phase 1 study of Postoperative Complications and Postoperative Pain, Acute that is actively recruiting participants, run by Swedish Medical Center. The registered enrollment target is 30 participants, below the 560-participant average among 20 other Postoperative Complications trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05906134, a Phase 1 study of Postoperative Complications and Postoperative Pain, Acute, is actively recruiting participants, sponsored by Swedish Medical Center.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
A pilot randomized controlled trial comparing intercostal nerve blocks, cryo-ablation plus intercostal nerve blocks, and serratus plane catheter plus intercostal nerve blocks in patients undergoing esophagectomies with minimally invasive thoracic approaches.
Primary Outcome
Compare post-operative pain score changes over time between intercostal nerve blocks, cryo-analgesia, and serratus plane catheters in patients undergoing minimally invasive esophagectomy. Patients will be asked specifically about thoracic/chest pain and asked to rate this pain on a Likert pain scale of 0-10, 0 being no pain and 10 being the worst pain they can imagine.
Conditions Studied
Interventions
- PROCEDURE Local intercostal nerve block
- PROCEDURE Cryo-analgesia and intercostal nerve block
- PROCEDURE Serratus plane catheter blocks and intercostal nerve blocks
- PROCEDURE Thoracic epidural catheter
Study Locations (1)
Washington
- Swedish Cancer Institute - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2022-04-26 |
| Est. Completion | 2027-02 |
| Phase | Phase 1 |
What NCT05906134 shows while recruiting
NCT05906134 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 560-participant average among 20 other Postoperative Complications trials with a reported enrollment target (95% lower).
The record links to 2 conditions, with Postoperative Complications appearing as the primary indexed condition, and to 4 interventions - of which Local intercostal nerve block is the first listed.
NCT05906134 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT05906134 about?
NCT05906134 is a clinical study titled "Minimally Invasive Esophagectomy Pain Control Trial". A pilot randomized controlled trial comparing intercostal nerve blocks, cryo-ablation plus intercostal nerve blocks, and serratus plane catheter plus intercostal nerve blocks in patients undergoing esophagectomies with minimally invasive thoracic approaches.
What is the current status of trial NCT05906134?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 30 participants. The study started on 2022-04-26. Estimated completion is 2027-02.
What conditions does trial NCT05906134 study?
This clinical trial studies the following conditions: Postoperative Complications, Postoperative Pain, Acute.
What interventions are being tested in trial NCT05906134?
The interventions under investigation include: Local intercostal nerve block (PROCEDURE), Cryo-analgesia and intercostal nerve block (PROCEDURE), Serratus plane catheter blocks and intercostal nerve blocks (PROCEDURE), Thoracic epidural catheter (PROCEDURE).
Who is sponsoring clinical trial NCT05906134?
This trial is sponsored by Swedish Medical Center, which has 30 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05906134 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Postoperative Complications
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05906134's enrollment target sits among peer trials
30 19th of 20 higher than 1 of 20 other Postoperative Complications trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Postoperative Complications trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Study Evaluating the Safety of MOA-728 Administered Orally to Healthy Subjects
COMPLETED · Phase 1
-
Nutrition to Support Postoperative Recovery
RECRUITING · NA
-
The Effect of Intrawound Vancomycin Powder on Surgical Site Infection in Inguinal Lymph Node Dissection
RECRUITING · Phase 2
-
Studying How Outpatient Water affEcts Risks With Drains (SHOWER Study)
RECRUITING · NA
-
Alert Frequency, Nurse, and Patient Satisfaction With a wCVSM Software Across Health Care Systems and Cultures
RECRUITING
-
Role of Phosphatidylethanol in Predicting Perioperative Outcomes of Admitted Patients at UHCMC
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI